A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

NCT01193478 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV Infection

Interventions

DRUG: GS-5885
DRUG: Placebo
DRUG: GS-5885
DRUG: Placebo
DRUG: GS-5885
DRUG: Placebo
DRUG: GS-5885
DRUG: Placebo
DRUG: GS-5885
DRUG: Placebo
DRUG: GS-5885
DRUG: Placebo

Sponsor

Gilead Sciences